Control of cell migration: a tumour suppressor function for p53? (Q36397275)

13 August 2017

1 reference

title

Control of cell migration: a tumour suppressor function for p53? (English)

1 reference

13 August 2017

1 reference

2

Gilles Gadea

1 reference

13 August 2017

Lauréline Roger

1

1 reference

PubMed ID

16480340

13 August 2017

Pierre Roux

series ordinal

3

1 reference

13 August 2017

1 March 2006

1 reference

13 August 2017

12

1 reference

based on heuristic

inferred from page(s)

published in

Biology of the Cell

1 reference

13 August 2017

98

1 reference

13 August 2017

3

1 reference

13 August 2017

141-152

1 reference

Changes in p53 expression in mouse fibroblasts can modify motility and extracellular matrix organization.

13 August 2017

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

p53 expression during normal tissue regeneration in response to acute cutaneous injury in swine

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Activation and activities of the p53 tumour suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

RET/PTC1 oncogene signaling in PC Cl 3 thyroid cells requires the small GTP-binding protein Rho.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Regulation of the cytoskeleton: an oncogenic function for CDK inhibitors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

p27Kip1 modulates cell migration through the regulation of RhoA activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Activation of Rho is required for ligand-independent oncogenic signaling by a mutant epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Genetics of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Pak-1 expression increases with progression of colorectal carcinomas to metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Genomic analysis of metastasis reveals an essential role for RhoC

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Human smooth muscle alpha-actin gene is a transcriptional target of the p53 tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Taking cell-matrix adhesions to the third dimension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Rho proteins induce metastatic properties in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Cdc42--the centre of polarity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Integrin-mediated activation of Cdc42 controls cell polarity in migrating astrocytes through PKCzeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Cdc42 regulates GSK-3beta and adenomatous polyposis coli to control cell polarity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

A genetic model for colorectal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

The p53 proto-oncogene can act as a suppressor of transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Rho GTPases are over-expressed in human tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Regulation of Cdc42-mediated morphological effects: a novel function for p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

TNFalpha induces sequential activation of Cdc42- and p38/p53-dependent pathways that antagonistically regulate filopodia formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

The complexity of p53 modulation: emerging patterns from divergent signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Changes in p53 expression can modify cell shape of ras-transformed fibroblasts and epitheliocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Involvement of Rho family GTPases in p19Arf- and p53-mediated proliferation of primary mouse embryonic fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Rho family GTPases cooperate with p53 deletion to promote primary mouse embryonic fibroblast cell invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Modelling the molecular circuitry of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

The C terminus of p53 family proteins is a cell fate determinant

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Mdm2 promotes the rapid degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

p53 mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

A definitive role of RhoC in metastasis of orthotopic lung cancer in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

An essential part for Rho-associated kinase in the transcellular invasion of tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Rho GTPases in transformation and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

DNA microarrays identification of primary and secondary target genes regulated by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Cytoplasmic retention of mutant tsp53 is dependent on an intermediate filament protein (vimentin) scaffold.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

T antigen is bound to a host protein in SY40-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

The absence of p53 promotes metastasis in a novel somatic mouse model for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

High metastatic potential in mice inheriting a targeted p53 missense mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Tumor progression: Small GTPases and loss of cell-cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Role of Rho-family proteins in cell adhesion and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Wild-type but not mutant p53 activates the hepatocyte growth factor/scatter factor promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

A role for Rac in Tiam1-induced membrane ruffling and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

The interaction of p53 with the nuclear matrix is mediated by F-actin and modulated by DNA damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

The IARC TP53 database: new online mutation analysis and recommendations to users

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Stimulation of fibroblast chemotaxis by human recombinant tumor necrosis factor alpha (TNF-alpha) and a synthetic TNF-alpha 31-68 peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

An essential role for Rac in Ras transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

A role for Rho in Ras transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Cdc42 regulates anchorage-independent growth and is necessary for Ras transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Global genechip profiling to identify genes responsive to p53-induced growth arrest and apoptosis in human lung carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

The small GTPases Cdc42Hs, Rac1 and RhoG delineate Raf-independent pathways that cooperate to transform NIH3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Differential requirement for Rho family GTPases in an oncogenic insulin-like growth factor-I receptor-induced cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Dissecting p53 tumor suppressor functions in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Principles of tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Assessing TP53 status in human tumours to evaluate clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Metastasis suppressors alter the signal transduction of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

p53 mutant mice that display early ageing-associated phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Glycogen Synthase Kinase-3β (GSK3β) Binds to and Promotes the Actions of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

Nuclear accumulation of glycogen synthase kinase-3 during replicative senescence of human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBC20050058

21 January 2018

Identifiers

DOI

10.1042/BC20050058

1 reference

13 August 2017

1 reference

PubMed ID

16480340